SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001651308-19-000045
Filing Date
2019-05-09
Accepted
2019-05-09 16:32:52
Documents
104
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q beigene2019q110-q.htm 10-Q 1603775
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 11880
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 11967
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 10372
  Complete submission text file 0001651308-19-000045.txt   7498540

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bgne-20190331.xml EX-101.INS 1375580
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20190331.xsd EX-101.SCH 66907
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20190331_cal.xml EX-101.CAL 114467
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20190331_def.xml EX-101.DEF 308140
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20190331_lab.xml EX-101.LAB 769918
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20190331_pre.xml EX-101.PRE 491540
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37686 | Film No.: 19811093
SIC: 2834 Pharmaceutical Preparations